The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | Common Stock | 008064107 | 41,131,652 | 2,039,249 | SH | SOLE | 2,039,249 | 0 | 0 | ||
Akero Therapeutics, Inc. | Common Stock | 00973Y108 | 22,736,043 | 594,251 | SH | SOLE | 594,251 | 0 | 0 | ||
AvroBio, Inc. | Common Stock | 05455M100 | 4,541,381 | 4,541,381 | SH | SOLE | 4,541,381 | 0 | 0 | ||
Day One Biopharmaceuticals, Inc. | Common Stock | 23954D109 | 101,724,228 | 7,608,394 | SH | SOLE | 7,608,394 | 0 | 0 | ||
Disc Medicine, Inc. | Common Stock | 254604101 | 73,355,203 | 3,461,784 | SH | SOLE | 3,461,784 | 0 | 0 | ||
Dyne Therapeutics, Inc. | Common Stock | 26818M108 | 113,880,372 | 9,885,449 | SH | SOLE | 9,885,449 | 0 | 0 | ||
Generation Bio, Co. | Common Stock | 37148K100 | 35,601,781 | 8,279,484 | SH | SOLE | 8,279,484 | 0 | 0 | ||
Ikena Oncology, Inc. | Common Stock | 45175G108 | 17,312,714 | 5,018,178 | SH | SOLE | 5,018,178 | 0 | 0 | ||
Kymera Therapeutics, Inc. | Common Stock | 501575104 | 173,580,303 | 5,858,262 | SH | SOLE | 5,858,262 | 0 | 0 | ||
Magenta Therapeutics, Inc. | Common Stock | 55910K108 | 3,013,262 | 3,791,698 | SH | SOLE | 3,791,698 | 0 | 0 | ||
Replimune Group, Inc. | Common Stock | 76029N106 | 37,055,978 | 2,098,300 | SH | SOLE | 2,098,300 | 0 | 0 | ||
Spero Therapeutics, Inc. | Common Stock | 84833T103 | 1,495,182 | 1,031,160 | SH | SOLE | 1,031,160 | 0 | 0 | ||
Third Harmonic Bio, Inc. | Common Stock | 88427A107 | 44,940,379 | 10,907,859 | SH | SOLE | 10,907,859 | 0 | 0 | ||
Vigil Neuroscience, Inc. | Common Stock | 92673K108 | 57,142,996 | 5,836,874 | SH | SOLE | 5,836,874 | 0 | 0 | ||
Viridian Therapeutics, Inc. | Common Stock | 92790C104 | 2,291,432 | 90,072 | SH | SOLE | 90,072 | 0 | 0 | ||
Xilio Therapeutics, Inc. | Common Stock | 98422T100 | 8,747,120 | 2,759,344 | SH | SOLE | 2,759,344 | 0 | 0 |